Scholarly Index
Wei Gu
Dali University; 48,856 total citations; 218 total publications; best world rank #12
Dali University
48,856Total citations
218Total publications
91H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ferroptosis and cancer prognosis | Lifetime | 12 | CN 4 | 99.67 |
| Ubiquitin and proteasome pathways | Lifetime | 56 | CN 4 | 99.60 |
| Cancer-related Molecular Pathways | Lifetime | 60 | CN 1 | 99.67 |
| Epigenetics and DNA Methylation | Lifetime | 136 | CN 7 | 99.54 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 143 | CN 4 | 99.49 |
| RNA modifications and cancer | Lifetime | 302 | CN 29 | 99.29 |
| Sirtuins and Resveratrol in Medicine | Lifetime | 31 | CN 3 | 99.09 |
| Autophagy in Disease and Therapy | Lifetime | 194 | CN 23 | 98.53 |
| Histone Deacetylase Inhibitors Research | Lifetime | 145 | CN 8 | 98.42 |
| Epigenetics and DNA Methylation | 2021-2025 | 15 | CN 6 | 99.29 |
| RNA modifications and cancer | 2021-2025 | 52 | CN 34 | 99.34 |
| Ferroptosis and cancer prognosis | 2021-2025 | 28 | CN 22 | 99.45 |
| Cancer-related Molecular Pathways | 2021-2025 | 31 | CN 2 | 97.48 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 151 | CN 42 | 95.19 |
| Ubiquitin and proteasome pathways | 2021-2025 | 140 | CN 65 | 94.09 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 550 | CN 155 | 82.17 |